This week, there’s a significant development in the ongoing Valsartan multi-district litigation (MDL). The judge overseeing the case has selected five plaintiffs’ lawsuits to proceed to the next round of [...]
On December 16, 2024, the federal judge overseeing the Valsartan litigation confirmed the selection of five cases for the second set of bellwether trials. These trials are part of the [...]
After the postponement of the first lawsuit selected for a bellwether trial, a new case has been scheduled to kick off the trials. The first trial will now involve a [...]
As the first bellwether trial in the Valsartan multi-district litigation (MDL) draws near, we are seeing an increase in interest surrounding the case. This is a common development, and we [...]
Valsartan
Rating 4.8 / 5.0 (3400 total reviews)
